Effectiveness of Virtual Reality (VR) in the Management of Anxiety for Patients Undergoing
The purpose of this study is to evaluate the use and functionality of virtual reality (VR) during radiation therapy treatments for patients with prostate, breast, lung, or head and neck cancer.
| Condition(s) | Radiation Therapy, Virtual Reality |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The purpose of this study is to evaluate the use and functionality of virtual reality (VR) during radiation therapy treatments for patients with prostate, breast, lung, or head and neck cancer. |
| Who can participate | Patients: Inclusion Criteria: * Participants planned for radiation therapy for 15 or more treatments with non-neutron generating energies (10 MV or less) per study PI for prostate, breast, lung, or head and neck cancer. Neutrons have the potential to damage the VR headset device and are generated for energies above 10 MV. * Age 18 years or older at the time of consent. * Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 at the time of enrollment. * Ability to understand and the willingness to sign an IRB-approved informed consent document directly. Exclusion Criteria: * Previous radiation therapy * VR device is determined to impede the radiation dosage during the VR device simulation and treatment planning * Participants with primary brain tumors, brain metastases, and ca |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Wake Forest University Health Sciences |
| Locations | High Point, North Carolina, United States |
| Start date | 2026-05-07 |
| NCT ID | NCT07324577 |
| Official listing | https://clinicaltrials.gov/study/NCT07324577 |